Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways

Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways

Conditions: Cardiovascular Diseases; Cardiovascular Diseases Risk; Cardiac Conduction System Disease; Bundle/Fascicular Abnormalities; His-Purkinje Disease; Arrhythmias, Cardiac; Rhythm Phenotypes; Myocardial Ischemia; Syncope; Syncope Recurrent; Syncope and Collapse; Seizure Disorder; Sleep Apnea Syndrome, Obstructive; Decision Support Systems, Clinical; Heart Failure – NYHA II – IV; Heart Failure (for Example, Fluid Overload); HRV; Cardiopulmonary; Sudden Cardiac Arrest; Cardiac Arrest (CA); Ventricular Arrhythmias and Cardiac Arrest; Ventricular Fibrillation; QT Dispersion; Atrial Cardiomyopathy
Interventions: Device: COR Wearable ECG Monitoring; Other: Cor360 Clinician-Facing Decision-Aid Reporting
Sponsors: Peerbridge Health, Inc
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 21, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments